117
Views
234
CrossRef citations to date
0
Altmetric
DNA Dynamics and Chromosome Structure

Chk2 Phosphorylation of BRCA1 Regulates DNA Double-Strand Break Repair

, , , , , , , & show all
Pages 708-718 | Received 25 Jul 2003, Accepted 23 Oct 2003, Published online: 27 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (16)

Somnath Ghosh & Anu Ghosh. (2021) Activation of DNA damage response signaling in mammalian cells by ionizing radiation. Free Radical Research 55:8, pages 814-827.
Read now
Francien Talens, Mathilde Jalving, Jourik A. Gietema & Marcel A. Van Vugt. (2017) Therapeutic targeting and patient selection for cancers with homologous recombination defects. Expert Opinion on Drug Discovery 12:6, pages 565-581.
Read now
Dan Zhang, Bo Tang, Xia Xie, Yu-Feng Xiao, Shi-Ming Yang & Jian-Wei Zhang. (2015) The interplay between DNA repair and autophagy in cancer therapy. Cancer Biology & Therapy 16:7, pages 1005-1013.
Read now
Balaji Parameswaran, Huai-Chin Chiang, Yunzhe Lu, Julia Coates, Chu-Xia Deng, Richard Baer, Hui-Kuan Lin, Rong Li, Tanya T Paull & Yanfen Hu. (2015) Damage-induced BRCA1 phosphorylation by Chk2 contributes to the timing of end resection. Cell Cycle 14:3, pages 437-448.
Read now
Kathrin Davari, Samantha Frankenberger, Angelika Schmidt, Nils-Sebastian Tomi & Berit Jungnickel. (2014) Checkpoint kinase 2 is required for efficient immunoglobulin diversification. Cell Cycle 13:23, pages 3659-3669.
Read now
Tatjana Stankovic & Anna Skowronska. (2014) The role of ATM mutations and 11q deletions in disease progression in chronic lymphocytic leukemia. Leukemia & Lymphoma 55:6, pages 1227-1239.
Read now
Jarin Chun, Erika S. Buechelmaier & Simon N. Powell. (2013) Rad51 Paralog Complexes BCDX2 and CX3 Act at Different Stages in the BRCA1-BRCA2-Dependent Homologous Recombination Pathway. Molecular and Cellular Biology 33:2, pages 387-395.
Read now
Wei Chen, Xiaoqun Liu, Tiankui Qiao & Sujuan Yuan. (2012) Impact of CHK2-small interfering RNA on CpG ODN7909-enhanced radiosensitivity in lung cancer A549 cells. OncoTargets and Therapy 5, pages 425-431.
Read now
Andreas Höglund, Kerstin Strömvall, Yongmei Li, Linus Plym Forshell & Jonas A. Nilsson. (2011) Chk2 deficiency in Myc overexpressing lymphoma cells elicits a synergistic lethal response in combination with PARP inhibition. Cell Cycle 10:20, pages 3598-3607.
Read now
Adam D. Brown, Alison B. Claybon & Alexander J. R. Bishop. (2011) A Conditional Mouse Model for Measuring the Frequency of Homologous Recombination Events In Vivo in the Absence of Essential Genes. Molecular and Cellular Biology 31:17, pages 3593-3602.
Read now
Verena M. Kuhnert, Lisa A. Kachnic, Li Li, Martin Purschke, Liliana Gheorghiu, Richard Lee, Kathryn D. Held & Henning Willers. (2009) FANCD2-deficient human fibroblasts are hypersensitive to ionising radiation at oxygen concentrations of 0% and 3% but not under normoxic conditions. International Journal of Radiation Biology 85:6, pages 523-531.
Read now
Giacomo Buscemi, Luigi Carlessi, Laura Zannini, Sofia Lisanti, Enrico Fontanella, Silvana Canevari & Domenico Delia. (2006) DNA Damage-Induced Cell Cycle Regulation and Function of Novel Chk2 Phosphoresidues. Molecular and Cellular Biology 26:21, pages 7832-7845.
Read now
Rachel A. Freiberg, Ester M. Hammond, Mary Jo Dorie, Scott M. Welford & Amato J. Giaccia. (2006) DNA Damage during Reoxygenation Elicits a Chk2-Dependent Checkpoint Response. Molecular and Cellular Biology 26:5, pages 1598-1609.
Read now
Sang Soo Kim, Liu Cao, Cuiling Li, Xiaoling Xu, L. Julie Huber, Lewis A. Chodosh & Chu-Xia Deng. (2004) Uterus Hyperplasia and Increased Carcinogen-Induced Tumorigenesis in Mice Carrying a Targeted Mutation of the Chk2 Phosphorylation Site in Brca1. Molecular and Cellular Biology 24:21, pages 9498-9507.
Read now
Ranjit S. Bindra, Paul J. Schaffer, Alice Meng, Jennifer Woo, Kårstein Måseide, Matt E. Roth, Paul Lizardi, David W. Hedley, Robert G. Bristow & Peter M. Glazer. (2004) Down-Regulation of Rad51 and Decreased Homologous Recombination in Hypoxic Cancer Cells. Molecular and Cellular Biology 24:19, pages 8504-8518.
Read now

Articles from other publishers (218)

Irene Bottillo, Emanuele Savino, Silvia Majore, Claudia Mulargia, Michele Valiante, Alessandro Ferraris, Valentina Rossi, Francesca Svegliati, Maria Pia Ciccone, Francesca Brusco, Barbara Grammatico, Gianluca Di Giacomo, Simone Bargiacchi, Daniela D’Angelantonio & Paola Grammatico. (2022) Two unrelated cases with biallelic CHEK2 variants:a novel condition with constitutional chromosomal instability?. European Journal of Human Genetics 31:4, pages 474-478.
Crossref
Anna P. Loboda, Leonid S. Adonin, Svetlana D. Zvereva, Dmitri Y. Guschin, Tatyana V. Korneenko, Alexandra V. Telegina, Olga K. Kondratieva, Sofia E. Frolova, Nikolay B. Pestov & Nick A. Barlev. (2023) BRCA Mutations—The Achilles Heel of Breast, Ovarian and Other Epithelial Cancers. International Journal of Molecular Sciences 24:5, pages 4982.
Crossref
Eun Choi, Gil-im Mun, Joohyun Lee, Hanhee Lee, Jaeho Cho & Yun-Sil Lee. (2023) BRCA1 deficiency in triple-negative breast cancer: Protein stability as a basis for therapy. Biomedicine & Pharmacotherapy 158, pages 114090.
Crossref
Takuya Tsujino, Tomoaki Takai, Kunihiko Hinohara, Fu Gui, Takeshi Tsutsumi, Xiao Bai, Chenkui Miao, Chao Feng, Bin Gui, Zsofia Sztupinszki, Antoine Simoneau, Ning Xie, Ladan Fazli, Xuesen Dong, Haruhito Azuma, Atish D. Choudhury, Kent W. Mouw, Zoltan Szallasi, Lee Zou, Adam S. Kibel & Li Jia. (2023) CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. Nature Communications 14:1.
Crossref
Dibya Ranjan Jalli & Debasmita Pankaj Alone. 2023. Biomedical Applications and Toxicity of Nanomaterials. Biomedical Applications and Toxicity of Nanomaterials 229 256 .
Huicheng Qi, Megumi Kikuchi, Yuki Yoshino, Zhenzhou Fang, Kazune Ohashi, Takato Gotoh, Ryo Ideta, Ayako Ui, Shino Endo, Kei Otsuka, Norihisa Shindo, Kohsuke Gonda, Chikashi Ishioka, Yoshio Miki, Tokuro Iwabuchi & Natsuko Chiba. (2022) BRCA1 transports the DNA damage signal for CDDP ‐induced centrosome amplification through the centrosomal Aurora A . Cancer Science 113:12, pages 4230-4243.
Crossref
Robert Hromas, Gayathri Srinivasan, Ming Yang, Aruna Jaiswal, Taylor A. Totterdale, Linda Phillips, Austin Kirby, Nazli Khodayari, Mark Brantley, Elizabeth A. Williamson & Kimi Y. Kong. (2022) BRCA1 mediates protein homeostasis through the ubiquitination of PERK and IRE1. iScience 25:12, pages 105626.
Crossref
Lia Yedidia-Aryeh & Michal Goldberg. (2022) The Interplay between the Cellular Response to DNA Double-Strand Breaks and Estrogen. Cells 11:19, pages 3097.
Crossref
Rick A.C.M. Boonen, Maaike P.G. Vreeswijk & Haico van Attikum. (2022) CHEK2 variants: linking functional impact to cancer risk. Trends in Cancer 8:9, pages 759-770.
Crossref
Leilei Qi, Reka Chakravarthy, Monica M. Li, Chu-Xia Deng, Rong Li & Yanfen Hu. (2022) Phosphorylation of BRCA1 by ATM upon double-strand breaks impacts ATM function in end-resection: A potential feedback loop. iScience 25:9, pages 104944.
Crossref
Alexandra Daks, Olga Fedorova, Sergey Parfenyev, Ivan Nevzorov, Oleg Shuvalov & Nickolai A. Barlev. (2022) The Role of E3 Ligase Pirh2 in Disease. Cells 11:9, pages 1515.
Crossref
Dongju Park, Mehdi Gharghabi, Colleen R. Reczek, Rebecca Plow, Charles Yungvirt, C. Marcelo Aldaz & Kay Huebner. (2022) Wwox Binding to the Murine Brca1-BRCT Domain Regulates Timing of Brip1 and CtIP Phospho-Protein Interactions with This Domain at DNA Double-Strand Breaks, and Repair Pathway Choice. International Journal of Molecular Sciences 23:7, pages 3729.
Crossref
Diego Teyssonneau, Antoine Thiery-Vuillemin, Charles Dariane, Eric Barret, Jean-Baptiste Beauval, Laurent Brureau, Gilles Créhange, Gaëlle Fiard, Gaëlle Fromont, Mathieu Gauthé, Alain Ruffion, Raphaële Renard-Penna, Romain Mathieu, Paul Sargos, Morgan Rouprêt, Guillaume Ploussard & Guilhem Roubaud. (2022) PARP Inhibitors as Monotherapy in Daily Practice for Advanced Prostate Cancers. Journal of Clinical Medicine 11:6, pages 1734.
Crossref
Rick A.C.M. Boonen, Wouter W. Wiegant, Nandi Celosse, Bas Vroling, Stephan Heijl, Zsofia Kote-Jarai, Martina Mijuskovic, Simona Cristea, Nienke Solleveld-Westerink, Tom van Wezel, Niko Beerenwinkel, Rosalind Eeles, Peter Devilee, Maaike P.G. Vreeswijk, Giancarlo Marra & Haico van Attikum. (2022) Functional Analysis Identifies Damaging CHEK2 Missense Variants Associated with Increased Cancer Risk . Cancer Research 82:4, pages 615-631.
Crossref
Jiaxin Yin, Min Yao, Hongdi Lu, Xiaofeng Cong, Pengfei Cui & Ziling Liu. (2021) Primary uterine broad ligament ependymoma with CHEK2 p. H371Y germline mutation: A CARE ‐compliant case report uterine broad ligament ependymoma . Journal of Obstetrics and Gynaecology Research 48:1, pages 266-270.
Crossref
Forough Alemi, Aydin Raei sadigh, Faezeh Malakoti, Yusuf Elhaei, Seyed Hamed Ghaffari, Masomeh Maleki, Zatollah Asemi, Bahman Yousefi, Niloufar Targhazeh & Maryam Majidinia. (2021) Molecular mechanisms involved in DNA repair in human cancers: An overview of PI3k/Akt signaling and PIKKs crosstalk. Journal of Cellular Physiology 237:1, pages 313-328.
Crossref
Diego Teyssonneau, Henri Margot, Mathilde Cabart, Mylène Anonnay, Paul Sargos, Nam-Son Vuong, Isabelle Soubeyran, Nicolas Sevenet & Guilhem Roubaud. (2021) Prostate cancer and PARP inhibitors: progress and challenges. Journal of Hematology & Oncology 14:1.
Crossref
Hartwig Visser & Adam D. Thomas. (2021) MicroRNAs and the DNA damage response: How is cell fate determined?. DNA Repair 108, pages 103245.
Crossref
Jae Jin Kim, Seo Yun Lee, Yiseul Hwang, Soyeon Kim, Jee Min Chung, Sangwook Park, Junghyun Yoon, Hansol Yun, Jae-Hoon Ji, Sunyoung Chae, Hyeseong Cho, Chan Gil Kim, Ted M Dawson, Hongtae Kim, Valina L Dawson & Ho Chul Kang. (2021) USP39 promotes non-homologous end-joining repair by poly(ADP-ribose)-induced liquid demixing. Nucleic Acids Research 49:19, pages 11083-11102.
Crossref
Angelo Taglialatela, Giuseppe Leuzzi, Vincenzo Sannino, Raquel Cuella-Martin, Jen-Wei Huang, Foon Wu-Baer, Richard Baer, Vincenzo Costanzo & Alberto Ciccia. (2021) REV1-Polζ maintains the viability of homologous recombination-deficient cancer cells through mutagenic repair of PRIMPOL-dependent ssDNA gaps. Molecular Cell 81:19, pages 4008-4025.e7.
Crossref
Tzeh K. Foo, Gabriele Vincelli, Eric Huselid, Joonyoung Her, Haiyan Zheng, Srilatha Simhadri, Meiling Wang, Yanying Huo, Tao Li, Xiaochun Yu, Hong Li, Weixing Zhao, Samuel F. Bunting & Bing Xia. (2021) ATR/ATM-Mediated Phosphorylation of BRCA1 T1394 Promotes Homologous Recombinational Repair and G2–M Checkpoint Maintenance. Cancer Research 81:18, pages 4676-4684.
Crossref
Mohsen Rashid, Leila Rostami Zadeh, Behzad Baradaran, Ommoleila Molavi, Zeinab Ghesmati, Mehdi Sabzichi & Fatemeh Ramezani. (2021) Up-down regulation of HIF-1α in cancer progression. Gene 798, pages 145796.
Crossref
Lidong Wang, Xiaodan Sun, Jingni He & Zhen Liu. (2021) Functions and Molecular Mechanisms of Deltex Family Ubiquitin E3 Ligases in Development and Disease. Frontiers in Cell and Developmental Biology 9.
Crossref
Esin Orhan, Carolina Velazquez, Imene Tabet, Claude Sardet & Charles Theillet. (2021) Regulation of RAD51 at the Transcriptional and Functional Levels: What Prospects for Cancer Therapy?. Cancers 13:12, pages 2930.
Crossref
Jeremy Setton, Jorge S Reis-Filho & Simon N Powell. (2021) Homologous recombination deficiency: how genomic signatures are generated. Current Opinion in Genetics & Development 66, pages 93-100.
Crossref
Lenka Stolarova, Petra Kleiblova, Marketa Janatova, Jana Soukupova, Petra Zemankova, Libor Macurek & Zdenek Kleibl. (2020) CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate. Cells 9:12, pages 2675.
Crossref
Fatemeh Sadeghi, Marzieh Asgari, Mojdeh Matloubi, Maral Ranjbar, Nahid Karkhaneh Yousefi, Tahereh Azari & Majid Zaki-Dizaji. (2020) Molecular contribution of BRCA1 and BRCA2 to genome instability in breast cancer patients: review of radiosensitivity assays. Biological Procedures Online 22:1.
Crossref
Xuehai Wang, Xin Zhang, Chen Qiu & Ning Yang. (2020) STAT3 Contributes to Radioresistance in Cancer. Frontiers in Oncology 10.
Crossref
Kristyna Tomasova, Andrea Cumova, Karolina Seborova, Josef Horak, Kamila Koucka, Ludmila Vodickova, Radka Vaclavikova & Pavel Vodicka. (2020) DNA Repair and Ovarian Carcinogenesis: Impact on Risk, Prognosis and Therapy Outcome. Cancers 12:7, pages 1713.
Crossref
Eleni Petsalaki & George Zachos. (2020) DNA damage response proteins regulating mitotic cell division: double agents preserving genome stability. The FEBS Journal 287:9, pages 1700-1721.
Crossref
Shijie Wu, Jiaojiao Zhou, Kun Zhang, Huihui Chen, Meng Luo, Yuexin Lu, Yuting Sun & Yiding Chen. (2020) Molecular Mechanisms of PALB2 Function and Its Role in Breast Cancer Management. Frontiers in Oncology 10.
Crossref
Y. Garcia-Mayea, C. Mir, F. Masson, R. Paciucci & M.E. LLeonart. (2020) Insights into new mechanisms and models of cancer stem cell multidrug resistance. Seminars in Cancer Biology 60, pages 166-180.
Crossref
Chinnadurai Mani, Shirisha Jonnalagadda, Jojireddy Lingareddy, Sanjay Awasthi, William H. Gmeiner & Komaraiah Palle. (2019) Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cells. Breast Cancer Research 21:1.
Crossref
Jinhuan Wu, Yuping Chen, Guohe Geng, Lei Li, Ping Yin, Somaira Nowsheen, Yunhui Li, Chenming Wu, Jiaqi Liu, Fei Zhao, Wootae Kim, Qin Zhou, Jinzhou Huang, Guijie Guo, Chao Zhang, Xinyi Tu, Xiumei Gao, Zhenkun Lou, Kuntian Luo, Haixuan Qiao & Jian Yuan. (2019) USP39 regulates DNA damage response and chemo-radiation resistance by deubiquitinating and stabilizing CHK2. Cancer Letters 449, pages 114-124.
Crossref
Xuan Jiang, Xiaoying Li, Weihua Li, Huimin Bai & Zhenyu Zhang. (2019) PARP inhibitors in ovarian cancer: Sensitivity prediction and resistance mechanisms. Journal of Cellular and Molecular Medicine 23:4, pages 2303-2313.
Crossref
Isabelle Cusin, Daniel Teixeira, Monique Zahn-Zabal, Valentine Rech de Laval, Anne Gleizes, Valeria Viassolo, Pierre O. Chappuis, Pierre Hutter, Amos Bairoch & Pascale Gaudet. (2018) A new bioinformatics tool to help assess the significance of BRCA1 variants. Human Genomics 12:1.
Crossref
Megan L. Sierant & Scott K. Davey. (2018) Identification and characterization of a novel nuclear structure containing members of the homologous recombination and DNA damage response pathways. Cancer Genetics 228-229, pages 98-109.
Crossref
Li Dong, Nan Wu, Shaojing Wang, Yanan Cheng, Lei Han, Jing Zhao, Xinxin Long, Kun Mu, Menghui Li, Lijuan Wei, Wanheng Wang, Weijia Zhang, Yandong Cao, Juntian Liu, Jinpu Yu & Xishan Hao. (2018) Detection of novel germline mutations in six breast cancer predisposition genes by targeted next-generation sequencing. Human Mutation 39:10, pages 1442-1455.
Crossref
Mahdiyeh PashaeiJamal Eivazi ZiaeiAlireza NikanfarBabak EmamalizadehSeyyed Mojtaba Mohaddes Ardebili. (2018) Study of Some Genetic Variants for Cancer in Women with Breast Cancer In the East Azarbaijan Region by MLPA Method. Biosciences, Biotechnology Research Asia 15:3, pages 671-677.
Crossref
Junya Tomida, Kei‐ichi Takata, Sarita Bhetawal, Maria D Person, Hsueh‐Ping Chao, Dean G Tang & Richard D Wood. (2018) FAM 35A associates with REV 7 and modulates DNA  damage responses of normal and BRCA 1‐defective cells . The EMBO Journal 37:12.
Crossref
Satheesh Kumar Sengodan, Sreelatha K.H.Revathy Nadhan & Priya Srinivas. (2018) Regulation of epithelial to mesenchymal transition by BRCA1 in breast cancer. Critical Reviews in Oncology/Hematology 123, pages 74-82.
Crossref
Sanghamitra Mylavarapu, Asmita Das & Monideepa Roy. (2018) Role of BRCA Mutations in the Modulation of Response to Platinum Therapy. Frontiers in Oncology 8.
Crossref
Himanshu Joshi & Michael F. Press. 2018. The Breast. The Breast 282 307.e5 .
Seamus P. Caragher, Sean Sachdev & Atique U. Ahmed. (2017) Radiotherapy and Glioma Stem Cells: Searching for Chinks in Cellular Armor. Current Stem Cell Reports 3:4, pages 348-357.
Crossref
Robert W Mutter, Nadeem Riaz, Charlotte KY Ng, Rob Delsite, Salvatore Piscuoglio, Marcia Edelweiss, Luciano G Martelotto, Rita A Sakr, Tari A King, Dilip D Giri, Maria Drobnjak, Edi Brogi, Ranjit Bindra, Giana Bernheim, Raymond S Lim, Pedro Blecua, Alexis Desrichard, Dan Higginson, Russell Towers, Ruomu Jiang, William Lee, Britta Weigelt, Jorge S Reis-Filho & Simon N Powell. (2017) Bi-allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer. The Journal of Pathology 242:2, pages 165-177.
Crossref
Reem Ali, Emad A. Rakha, Srinivasan Madhusudan & Helen E. Bryant. (2017) DNA damage repair in breast cancer and its therapeutic implications. Pathology 49:2, pages 156-165.
Crossref
S. Liang, S. R. Esswein, T. Ochi, Q. Wu, D. B. Ascher, D. Chirgadze, B. L. Sibanda & T. L. Blundell. (2016) Achieving selectivity in space and time with DNA double-strand-break response and repair: molecular stages and scaffolds come with strings attached. Structural Chemistry 28:1, pages 161-171.
Crossref
C García-Limones, M Lara-Chica, C Jiménez-Jiménez, M Pérez, P Moreno, E Muñoz & M A Calzado. (2016) CHK2 stability is regulated by the E3 ubiquitin ligase SIAH2. Oncogene 35:33, pages 4289-4301.
Crossref
Yao Zhang, Jinzhi Lai, Zhanwen Du, Jinnan Gao, Shuming Yang, Shashank Gorityala, Xiahui Xiong, Ou Deng, Zhefu Ma, Chunhong Yan, Gonzalo Susana, Yan Xu & Junran Zhang. (2016) Targeting radioresistant breast cancer cells by single agent CHK1 inhibitor via enhancing replication stress. Oncotarget 7:23, pages 34688-34702.
Crossref
Pounami Samadder, Rakesh Aithal, Ondrej Belan & Lumir Krejci. (2016) Cancer TARGETases: DSB repair as a pharmacological target. Pharmacology & Therapeutics 161, pages 111-131.
Crossref
Irene Guendel, Beatrix W Meltzer, Alan Baer, Seth M Dever, Kristoffer Valerie, Jia Guo, Yuntao Wu & Kylene Kehn-Hall. (2015) BRCA1 functions as a novel transcriptional cofactor in HIV-1 infection. Virology Journal 12:1.
Crossref
Yin Liu, Ye Xu, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin & Yuntao Xie. (2015) Association between CHEK2 H371Y mutation and response to neoadjuvant chemotherapy in women with breast cancer. BMC Cancer 15:1.
Crossref
Yung-Hao Wong, Chih-Lung Lin, Ting-Shou Chen, Chien-An Chen, Pei-Shin Jiang, Yi-Hua Lai, Lichieh Julie Chu, Cheng-Wei Li, Jeremy JW Chen & Bor-Sen Chen. (2015) Multiple target drug cocktail design for attacking the core network markers of four cancers using ligand-based and structure-based virtual screening methods. BMC Medical Genomics 8:S4.
Crossref
R.K.K. Lam, Wei Han & K.N. Yu. (2015) Unirradiated cells rescue cells exposed to ionizing radiation: Activation of NF-κB pathway in irradiated cells. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 782, pages 23-33.
Crossref
Wei-Ling Chang, Lih-Ching Hsu, Wohn-Jenn Leu, Ching-Shih Chen & Jih-Hwa Guh. (2015) Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer - a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation. Oncotarget 6:37, pages 39806-39820.
Crossref
Denis Velic, Anthony Couturier, Maria Ferreira, Amélie Rodrigue, Guy Poirier, Fabrice Fleury & Jean-Yves Masson. (2015) DNA Damage Signalling and Repair Inhibitors: The Long-Sought-After Achilles’ Heel of Cancer. Biomolecules 5:4, pages 3204-3259.
Crossref
Adrian P. Wiegmans, Pei-Yi Yap, Ambber Ward, Yi Chieh Lim & Kum Kum Khanna. (2015) Differences in Expression of Key DNA Damage Repair Genes after Epigenetic-Induced BRCAness Dictate Synthetic Lethality with PARP1 Inhibition. Molecular Cancer Therapeutics 14:10, pages 2321-2331.
Crossref
Henning Willers, Liliana Gheorghiu, Qi Liu, Jason A. Efstathiou, Lori J. Wirth, Mechthild Krause & Cläre von Neubeck. (2015) DNA Damage Response Assessments in Human Tumor Samples Provide Functional Biomarkers of Radiosensitivity. Seminars in Radiation Oncology 25:4, pages 237-250.
Crossref
Charlene Kan & Junran Zhang. (2015) BRCA1 Mutation: A Predictive Marker for Radiation Therapy?. International Journal of Radiation Oncology*Biology*Physics 93:2, pages 281-293.
Crossref
Jason M. Beckta, Seth M. Dever, Nisha Gnawali, Ashraf Khalil, Amrita Sule, Sarah E. Golding, Elizabeth Rosenberg, Aarthi Narayanan, Kylene Kehn-Hall, Bo Xu, Lawrence F. Povirk & Kristoffer Valerie. (2015) Mutation of the BRCA1 SQ-cluster results in aberrant mitosis, reduced homologous recombination, and a compensatory increase in non-homologous end joining. Oncotarget 6:29, pages 27674-27687.
Crossref
Chao Dong, Fengmei Zhang, Yue Luo, Hui Wang, Xipeng Zhao, Gongshe Guo, Simon N. Powell & Zhihui Feng. (2015) p53 suppresses hyper-recombination by modulating BRCA1 function. DNA Repair 33, pages 60-69.
Crossref
D Kraft, M Rall, M Volcic, E Metzler, A Groo, A Stahl, L Bauer, E Nasonova, D Salles, G Taucher-Scholz, H Bönig, C Fournier & L Wiesmüller. (2015) NF-κB-dependent DNA damage-signaling differentially regulates DNA double-strand break repair mechanisms in immature and mature human hematopoietic cells. Leukemia 29:7, pages 1543-1554.
Crossref
Pawel Domagala, Anna Jakubowska, Katarzyna Jaworska-Bieniek, Katarzyna Kaczmarek, Katarzyna Durda, Agnieszka Kurlapska, Cezary Cybulski & Jan Lubinski. (2015) Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast Cancers. PLOS ONE 10:6, pages e0130393.
Crossref
Saeko Takada, Eric R. Collins & Kayo Kurahashi. (2015) The FHA domain determines Drosophila Chk2/Mnk localization to key mitotic structures and is essential for early embryonic DNA damage responses . Molecular Biology of the Cell 26:10, pages 1811-1828.
Crossref
Lucheng Zhu, Kan Wu, Shenglin Ma & Shirong Zhang. (2015) HDAC Inhibitors: A New Radiosensitizer for Non-small-cell Lung Cancer. Tumori Journal 101:3, pages 257-262.
Crossref
Nicholas A. Wallace, Kristin Robinson, Heather L. Howie & Denise A. Galloway. (2015) β-HPV 5 and 8 E6 Disrupt Homology Dependent Double Strand Break Repair by Attenuating BRCA1 and BRCA2 Expression and Foci Formation. PLOS Pathogens 11:3, pages e1004687.
Crossref
Małgorzata Krajewska, Rudolf S. N. Fehrmann, Elisabeth G. E. de Vries & Marcel A. T. M. van Vugt. (2015) Regulators of homologous recombination repair as novel targets for cancer treatment. Frontiers in Genetics 6.
Crossref
Xiahui Xiong, Zhanwen Du, Ying Wang, Zhihui Feng, Pan Fan, Chunhong Yan, Henning Willers & Junran Zhang. (2015) 53BP1 promotes microhomology-mediated end-joining in G1-phase cells. Nucleic Acids Research 43:3, pages 1659-1670.
Crossref
Oleg Alekseev, Vladimir Limonnik, Kelly Donovan & Jane Azizkhan-Clifford. (2015) Activation of Checkpoint Kinase 2 Is Critical for Herpes Simplex Virus Type 1 Replication in Corneal Epithelium. Ophthalmic Research 53:2, pages 55-64.
Crossref
Seungyoon Nam, Hae Ryung Chang, Hae Rim Jung, Youme Gim, Nam Youl Kim, Regis Grailhe, Haeng Ran Seo, Hee Seo Park, Curt Balch, Jinhyuk Lee, Inhae Park, So Youn Jung, Kyung-Chae Jeong, Garth Powis, Han Liang, Eun Sook Lee, Jungsil Ro & Yon Hui Kim. (2015) A pathway-based approach for identifying biomarkers of tumor progression to trastuzumab-resistant breast cancer. Cancer Letters 356:2, pages 880-890.
Crossref
Jennifer A. Stanley & Eddy S. Yang. 2015. PARP Inhibitors for Cancer Therapy. PARP Inhibitors for Cancer Therapy 381 412 .
Helen E. Bryant & Sydney Shall. 2015. PARP Inhibitors for Cancer Therapy. PARP Inhibitors for Cancer Therapy 315 344 .
L. Zannini, D. Delia & G. Buscemi. (2014) CHK2 kinase in the DNA damage response and beyond. Journal of Molecular Cell Biology 6:6, pages 442-457.
Crossref
Jung-Young Park, Fan Zhang & Paul R. Andreassen. (2014) PALB2: The hub of a network of tumor suppressors involved in DNA damage responses. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1846:1, pages 263-275.
Crossref
Jung Eun Yeo, Eu Han Lee, Eric A. Hendrickson & Alexandra Sobeck. (2014) CtIP mediates replication fork recovery in a FANCD2-regulated manner. Human Molecular Genetics 23:14, pages 3695-3705.
Crossref
Wil L. SantivasiFen Xia. (2014) Ionizing Radiation-Induced DNA Damage, Response, and Repair. Antioxidants & Redox Signaling 21:2, pages 251-259.
Crossref
Chun-Wei Yeh, Zheng-Cheng Yu, Peng-Hsu Chen, Yu-Che Cheng & Sheau-Yann Shieh. (2014) Phosphorylation at Threonine 288 by Cell Cycle Checkpoint Kinase 2 (CHK2) Controls Human Monopolar Spindle 1 (Mps1) Kinetochore Localization. Journal of Biological Chemistry 289:22, pages 15319-15327.
Crossref
Zhan Zhang, Huiyuan Lu, Fei Huan, Cromie Meghan, Xuejiao Yang, Yun Wang, Xichen Wang, Xinru Wang & Shou-Lin Wang. (2014) Cytochrome P450 2A13 mediates the neoplastic transformation of human bronchial epithelial cells at a low concentration of aflatoxin B1. International Journal of Cancer 134:7, pages 1539-1548.
Crossref
Z Shang, L Yu, Y-F Lin, S Matsunaga, C-Y Shen & B P C Chen. (2014) DNA-PKcs activates the Chk2–Brca1 pathway during mitosis to ensure chromosomal stability. Oncogenesis 3:2, pages e85-e85.
Crossref
Joris R Julsing & Godefridus J Peters. (2014) Methylation of DNA repair genes and the efficacy of DNA targeted anticancer treatment. Oncology Discovery 2:1, pages 3.
Crossref
Laura B. Kleiman, Angela M. Krebs, Stephen Y. Kim, Theodore S. Hong & Kevin M. Haigis. (2013) Comparative Analysis of Radiosensitizers for K-RAS Mutant Rectal Cancers. PLoS ONE 8:12, pages e82982.
Crossref
Libero SantarpiaTakayuki IwamotoAngelo Di LeoNaoki HayashiGiulia BottaiMartha StampferFabrice AndréNicholas C. TurnerW. Fraser SymmansGabriel N. HortobágyiLajos PusztaiGiampaolo Bianchini. (2013) DNA Repair Gene Patterns as Prognostic and Predictive Factors in Molecular Breast Cancer Subtypes. The Oncologist 18:10, pages 1063-1073.
Crossref
Zhan Zhang, Xuejiao Yang, Yun Wang, Xichen Wang, Huiyuan Lu, Xiaoming Zhang, Xue Xiao, Shushu Li, Xinru Wang & Shou-Lin Wang. (2013) Cytochrome P450 2A13 is an efficient enzyme in metabolic activation of aflatoxin G1 in human bronchial epithelial cells. Archives of Toxicology 87:9, pages 1697-1707.
Crossref
B H Lok, A C Carley, B Tchang & S N Powell. (2012) RAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination. Oncogene 32:30, pages 3552-3558.
Crossref
M. Cris Silva-Santisteban, Isaac M. Westwood, Kathy Boxall, Nathan Brown, Sam Peacock, Craig McAndrew, Elaine Barrie, Meirion Richards, Amin Mirza, Antony W. Oliver, Rosemary Burke, Swen Hoelder, Keith Jones, G. Wynne Aherne, Julian Blagg, Ian Collins, Michelle D. Garrett & Rob L. M. van Montfort. (2013) Fragment-Based Screening Maps Inhibitor Interactions in the ATP-Binding Site of Checkpoint Kinase 2. PLoS ONE 8:6, pages e65689.
Crossref
Jhoana Mendoza, Michiko Sekiya, Taizo Taniguchi, Koichi M. Iijima, Rong Wang & Kanae Ando. (2013) Global Analysis of Phosphorylation of Tau by the Checkpoint Kinases Chk1 and Chk2 in vitro . Journal of Proteome Research 12:6, pages 2654-2665.
Crossref
Eric Tram, Sevtap Savas & Hilmi Ozcelik. (2013) Missense Variants of Uncertain Significance (VUS) Altering the Phosphorylation Patterns of BRCA1 and BRCA2. PLoS ONE 8:5, pages e62468.
Crossref
Claudio Scafoglio, Marcus Smolka, Huilin Zhou, Valentina Perissi & Michael G. Rosenfeld. (2013) The Co-Repressor SMRT Delays DNA Damage-Induced Caspase Activation by Repressing Pro-Apoptotic Genes and Modulating the Dynamics of Checkpoint Kinase 2 Activation. PLoS ONE 8:5, pages e59986.
Crossref
Moritz Birkelbach, Natalie Ferraiolo, Liliana Gheorghiu, Heike N. Pfäffle, Benedict Daly, Michael I. Ebright, Cheryl Spencer, Carl O'Hara, Johnathan R. Whetstine, Cyril H. Benes, Lecia V. Sequist, Lee Zou, Jochen Dahm-Daphi, Lisa A. Kachnic & Henning Willers. (2013) Detection of Impaired Homologous Recombination Repair in NSCLC Cells and Tissues. Journal of Thoracic Oncology 8:3, pages 279-286.
Crossref
A. Gutiérrez-González, C. Belda-Iniesta, J. Bargiela-Iparraguirre, G. Dominguez, P. García Alfonso, R. Perona & I. Sanchez-Perez. (2012) Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair. Apoptosis 18:3, pages 347-360.
Crossref
. 2013. DNA Repair and Cancer. DNA Repair and Cancer 111 112 .
Mihoko Kai. (2013) Role of the Checkpoint Clamp in DNA Damage Response. Biomolecules 3:4, pages 75-84.
Crossref
Charita Christou & Kyriacos Kyriacou. (2013) BRCA1 and Its Network of Interacting Partners. Biology 2:1, pages 40-63.
Crossref
Junran Zhang. (2013) The role of BRCA1 in homologous recombination repair in response to replication stress: significance in tumorigenesis and cancer therapy. Cell & Bioscience 3:1, pages 11.
Crossref
Wil L Santivasi & Fen Xia. (2013) The role and clinical significance of DNA damage response and repair pathways in primary brain tumors. Cell & Bioscience 3:1, pages 10.
Crossref
Rémi Buisson & Jean-Yves Masson. (2012) PALB2 self-interaction controls homologous recombination. Nucleic Acids Research 40:20, pages 10312-10323.
Crossref
Larry H. Thompson. (2012) Recognition, signaling, and repair of DNA double-strand breaks produced by ionizing radiation in mammalian cells: The molecular choreography. Mutation Research/Reviews in Mutation Research 751:2, pages 158-246.
Crossref
Veena Somasundaram & Priya Srinivas. (2012) Insights into the targeted elimination of BRCA1-defective cancer stem cells. Medicinal Research Reviews 32:5, pages 948-967.
Crossref
Dulcie Lai, Stacy Visser-Grieve & Xiaolong Yang. (2012) Tumour suppressor genes in chemotherapeutic drug response. Bioscience Reports 32:4, pages 361-374.
Crossref
Yoshiko Shimizu, Nicole Mullins, Zannel Blanchard & Wael M. ElShamy. (2012) BRCA1/p220 loss triggers BRCA1-IRIS overexpression via mRNA stabilization in breast cancer cells . Oncotarget 3:3, pages 299-313.
Crossref
Zhihui Feng & Junran Zhang. (2012) A dual role of BRCA1 in two distinct homologous recombination mediated repair in response to replication arrest. Nucleic Acids Research 40:2, pages 726-738.
Crossref
Meta Volcic, Sabine Karl, Bernd Baumann, Daniela Salles, Peter Daniel, Simone Fulda & Lisa Wiesmüller. (2012) NF-κB regulates DNA double-strand break repair in conjunction with BRCA1–CtIP complexes. Nucleic Acids Research 40:1, pages 181-195.
Crossref
Rohini Roy, Jarin Chun & Simon N. Powell. (2011) BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nature Reviews Cancer 12:1, pages 68-78.
Crossref
Henning Willers, Heike N. Pfäffle & Lee Zou. 2012. DNA Repair in Cancer Therapy. DNA Repair in Cancer Therapy 119 160 .
George T. Lountos, Andrew G. Jobson, Joseph E. Tropea, Christopher R. Self, Guangtao Zhang, Yves Pommier, Robert H. Shoemaker & David S. Waugh. (2011) Structural characterization of inhibitor complexes with checkpoint kinase 2 (Chk2), a drug target for cancer therapy. Journal of Structural Biology 176:3, pages 292-301.
Crossref
Marlen Keimling, Meta Volcic, Andreea Csernok, Britta Wieland, Thilo Dörk & Lisa Wiesmüller. (2011) Functional characterization connects individual patient mutations in ataxia telangiectasia mutated (ATM) with dysfunction of specific DNA double‐strand break‐repair signaling pathways . The FASEB Journal 25:11, pages 3849-3860.
Crossref
George T. Lountos, Andrew G. Jobson, Joseph E. Tropea, Christopher R. Self, Guangtao Zhang, Yves Pommier, Robert H. Shoemaker & David S. Waugh. (2011) X-ray structures of checkpoint kinase 2 in complex with inhibitors that target its gatekeeper-dependent hydrophobic pocket. FEBS Letters 585:20, pages 3245-3249.
Crossref
Shivani Ponnala, Krishna Kumar Veeravalli, Chandramu Chetty, Dzung H. Dinh & Jasti S. Rao. (2011) Regulation of DNA Repair Mechanism in Human Glioma Xenograft Cells both In Vitro and In Vivo in Nude Mice. PLoS ONE 6:10, pages e26191.
Crossref
Tomohiko Ohta, Ko Sato & Wenwen Wu. (2011) The BRCA1 ubiquitin ligase and homologous recombination repair. FEBS Letters 585:18, pages 2836-2844.
Crossref
Bianca M. Sirbu, Sarah J. Lachmayer, Verena Wülfing, Lara M. Marten, Katie E. Clarkson, Linda W. Lee, Liliana Gheorghiu, Lee Zou, Simon N. Powell, Jochen Dahm-Daphi & Henning Willers. (2011) ATR-p53 Restricts Homologous Recombination in Response to Replicative Stress but Does Not Limit DNA Interstrand Crosslink Repair in Lung Cancer Cells. PLoS ONE 6:8, pages e23053.
Crossref
Somnath Ghosh, Himanshi Narang, Asiti Sarma, Harminder Kaur & Malini Krishna. (2011) Activation of DNA damage response signaling in lung adenocarcinoma A549 cells following oxygen beam irradiation. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 723:2, pages 190-198.
Crossref
Isabelle Cousineau & Abdellah Belmaaza. (2011) EMSY overexpression disrupts the BRCA2/RAD51 pathway in the DNA-damage response: implications for chromosomal instability/recombination syndromes as checkpoint diseases. Molecular Genetics and Genomics 285:4, pages 325-340.
Crossref
Christian Orlowski, Li-Jeen Mah, Raja S. Vasireddy, Assam El-Osta & Tom C. Karagiannis. (2010) Double-strand breaks and the concept of short- and long-term epigenetic memory. Chromosoma 120:2, pages 129-149.
Crossref
Krystyna Mazan-MamczarzPatrick R. HagnerYongqing ZhangBojie DaiElin LehrmannKevin G. BeckerJack D. KeeneMyriam GorospeZhenqui LiuRonald B. Gartenhaus. (2011) ATM regulates a DNA damage response posttranscriptional RNA operon in lymphocytes. Blood 117:8, pages 2441-2450.
Crossref
Ailine Stolz, Norman Ertych & Holger Bastians. (2011) Tumor Suppressor CHK2 : Regulator of DNA Damage Response and Mediator of Chromosomal Stability . Clinical Cancer Research 17:3, pages 401-405.
Crossref
Victoria E. Anderson, Michael I. Walton, Paul D. Eve, Katherine J. Boxall, Laurent Antoni, John J. Caldwell, Wynne Aherne, Laurence H. Pearl, Antony W. Oliver, Ian Collins & Michelle D. Garrett. (2011) CCT241533 Is a Potent and Selective Inhibitor of CHK2 that Potentiates the Cytotoxicity of PARP Inhibitors. Cancer Research 71:2, pages 463-472.
Crossref
Zhihui Feng, Shaun P. Scott, Wendy Bussen, Girdhar G. Sharma, Gongshe Guo, Tej K. Pandita & Simon N. Powell. (2010) Rad52 inactivation is synthetically lethal with BRCA2 deficiency. Proceedings of the National Academy of Sciences 108:2, pages 686-691.
Crossref
Fred Bunz. 2011. Molecular Determinants of Radiation Response. Molecular Determinants of Radiation Response 35 52 .
Herman D. Suit & Jay S. LoefflerHerman D. Suit & Jay S. Loeffler. 2011. Evolution of Radiation Oncology at Massachusetts General Hospital. Evolution of Radiation Oncology at Massachusetts General Hospital 97 125 .
K. Somyajit, S. Subramanya & G. Nagaraju. (2010) RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer. Carcinogenesis 31:12, pages 2031-2038.
Crossref
Honghong Chen, Zhefu Ma, Robert P. Vanderwaal, Zhihui Feng, Ignacio Gonzalez-Suarez, Shenming Wang, Jiuqin Zhang, Joseph L. Roti Roti, Susana Gonzalo & Junran Zhang. (2010) The mTOR Inhibitor Rapamycin Suppresses DNA Double-Strand Break Repair. Radiation Research 175:2, pages 214.
Crossref
Luigi Carlessi, Giacomo Buscemi, Enrico Fontanella & Domenico Delia. (2010) A protein phosphatase feedback mechanism regulates the basal phosphorylation of Chk2 kinase in the absence of DNA damage. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1803:10, pages 1213-1223.
Crossref
Hong Wang, Eddy S. Yang, Juhong Jiang, Somaira Nowsheen & Fen Xia. (2010) DNA Damage–Induced Cytotoxicity Is Dissociated from BRCA1's DNA Repair Function but Is Dependent on Its Cytosolic Accumulation. Cancer Research 70:15, pages 6258-6267.
Crossref
Eddy S. Yang & Fen Xia. (2010) BRCA1 16 years later: DNA damage-induced BRCA1 shuttling. FEBS Journal 277:15, pages 3079-3085.
Crossref
Yan-Qiu Wang, Jia-Rong Zhang, Shuang-Di Li, Yin-Yan He, Yi-Xia Yang, Xue-Lian Liu & Xiao-Ping Wan. (2010) Aberrant methylation of breast and ovarian cancer susceptibility gene 1 in chemosensitive human ovarian cancer cells does not involve the phosphatidylinositol 3′-kinase-Akt pathway. Cancer Science 101:7, pages 1618-1623.
Crossref
Ronit I. Yarden, Eitan Friedman, Sally Metsuyanim, Tzvia Olender, Edna Ben-Asher & Moshe Z. Papa. (2010) Single-nucleotide polymorphisms in the p53 pathway genes modify cancer risk in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent. Molecular Carcinogenesis 49:6, pages 545-555.
Crossref
Timothy D. Wiltshire, Courtney A. Lovejoy, Tong Wang, Fen Xia, Mark J. O'Connor & David Cortez. (2010) Sensitivity to Poly(ADP-ribose) Polymerase (PARP) Inhibition Identifies Ubiquitin-specific Peptidase 11 (USP11) as a Regulator of DNA Double-strand Break Repair. Journal of Biological Chemistry 285:19, pages 14565-14571.
Crossref
Ailine Stolz, Norman Ertych, Anne Kienitz, Celia Vogel, Verena Schneider, Barbara Fritz, Ralf Jacob, Gunnar Dittmar, Wilko Weichert, Iver Petersen & Holger Bastians. (2010) The CHK2–BRCA1 tumour suppressor pathway ensures chromosomal stability in human somatic cells. Nature Cell Biology 12:5, pages 492-499.
Crossref
Ko Sato, Tomohiko Ohta & Ashok R. Venkitaraman. (2010) A mitotic role for the DNA damage-responsive CHK2 kinase. Nature Cell Biology 12:5, pages 424-425.
Crossref
IM Pires, TH Ward & C Dive. (2010) Oxaliplatin responses in colorectal cancer cells are modulated by CHK2 kinase inhibitors. British Journal of Pharmacology 159:6, pages 1326-1338.
Crossref
David Schild & Claudia Wiese. (2010) Overexpression of RAD51 suppresses recombination defects: a possible mechanism to reverse genomic instability. Nucleic Acids Research 38:4, pages 1061-1070.
Crossref
Michael S.Y. Huen, Shirley M.H. Sy & Junjie Chen. (2009) BRCA1 and its toolbox for the maintenance of genome integrity. Nature Reviews Molecular Cell Biology 11:2, pages 138-148.
Crossref
Michael S.Y. Huen & Junjie Chen. (2010) Assembly of checkpoint and repair machineries at DNA damage sites. Trends in Biochemical Sciences 35:2, pages 101-108.
Crossref
Stephen Hilton, Sebastien Naud, John J. Caldwell, Kathy Boxall, Samantha Burns, Victoria E. Anderson, Laurent Antoni, Charlotte E. Allen, Laurence H. Pearl, Antony W. Oliver, G. Wynne Aherne, Michelle D. Garrett & Ian Collins. (2010) Identification and characterisation of 2-aminopyridine inhibitors of checkpoint kinase 2. Bioorganic & Medicinal Chemistry 18:2, pages 707-718.
Crossref
Suhwan Chang, Kajal Biswas, Betty K. Martin, Stacey Stauffer & Shyam K. Sharan. (2009) Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations. Journal of Clinical Investigation 119:10, pages 3160-3171.
Crossref
Pablo Serrano-Fernández, Tadeusz Dębniak, Bohdan Górski, Natalia Bogdanova, Thilo Dörk, Cezary Cybulski, Tomasz Huzarski, Tomasz Byrski, Jacek Gronwald, Dominika Wokołorczyk, Steven A. Narod & Jan Lubiński. (2008) Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk. Breast Cancer Research and Treatment 117:1, pages 161-165.
Crossref
Henning Willers, Alphonse G. Taghian, Chen-Mei Luo, Alejandro Treszezamsky, Dennis C. Sgroi & Simon N. Powell. (2009) Utility of DNA Repair Protein Foci for the Detection of Putative BRCA1 Pathway Defects in Breast Cancer Biopsies. Molecular Cancer Research 7:8, pages 1304-1309.
Crossref
Fan Zhang, Qiang Fan, Keqin Ren & Paul R. Andreassen. (2009) PALB2 Functionally Connects the Breast Cancer Susceptibility Proteins BRCA1 and BRCA2. Molecular Cancer Research 7:7, pages 1110-1118.
Crossref
I Plo & B Lopez. (2009) AKT1 represses gene conversion induced by different genotoxic stresses and induces supernumerary centrosomes and aneuploidy in hamster ovary cells. Oncogene 28:22, pages 2231-2237.
Crossref
Shirley M. H. Sy, Michael S. Y. Huen & Junjie Chen. (2009) PALB2 is an integral component of the BRCA complex required for homologous recombination repair. Proceedings of the National Academy of Sciences 106:17, pages 7155-7160.
Crossref
Elizabeth Alli, Vandana B. Sharma, Preethi Sunderesakumar & James M. Ford. (2009) Defective Repair of Oxidative DNA Damage in Triple-Negative Breast Cancer Confers Sensitivity to Inhibition of Poly(ADP-Ribose) Polymerase. Cancer Research 69:8, pages 3589-3596.
Crossref
Ana Osorio, Alicia Barroso, Maria J. García, Beatriz Martínez-Delgado, Miguel Urioste & Javier Benítez. (2008) Evaluation of the BRCA1 interacting genes RAP80 and CCDC98 in familial breast cancer susceptibility. Breast Cancer Research and Treatment 113:2, pages 371-376.
Crossref
Antonio Russo, Valentina Agnese, Sergio Rizzo, Laura La Paglia & Viviana Bazan. 2009. Breast Cancer in the Post-Genomic Era. Breast Cancer in the Post-Genomic Era 39 54 .
Katherine L. Nathanson. 2010. The Role of Genetics in Breast and Reproductive Cancers. The Role of Genetics in Breast and Reproductive Cancers 131 162 .
Wen-Cheng Chou, Hui-Chun Wang, Fen-Hwa Wong, Shian-ling Ding, Pei-Ei Wu, Sheau-Yann Shieh & Chen-Yang Shen. (2008) Chk2-dependent phosphorylation of XRCC1 in the DNA damage response promotes base excision repair. The EMBO Journal 27:23, pages 3140-3150.
Crossref
Corinne Chabalier-Taste, Carine Racca, Christine Dozier & Florence Larminat. (2008) BRCA1 is regulated by Chk2 in response to spindle damage. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1783:12, pages 2223-2233.
Crossref
Liping Li, Hong Wang, Eddy S. Yang, Carlos L. Arteaga & Fen Xia. (2008) Erlotinib Attenuates Homologous Recombinational Repair of Chromosomal Breaks in Human Breast Cancer Cells. Cancer Research 68:22, pages 9141-9146.
Crossref
Mitch McVey & Sang Eun Lee. (2008) MMEJ repair of double-strand breaks (director’s cut): deleted sequences and alternative endings. Trends in Genetics 24:11, pages 529-538.
Crossref
Jun Yan & Anton M. Jetten. (2008) RAP80 and RNF8, key players in the recruitment of repair proteins to DNA damage sites. Cancer Letters 271:2, pages 179-190.
Crossref
J-M Brondello, M J Pillaire, C Rodriguez, P-A Gourraud, J Selves, C Cazaux & J Piette. (2008) Novel evidences for a tumor suppressor role of Rev3, the catalytic subunit of Pol ζ. Oncogene 27:47, pages 6093-6101.
Crossref
Rosario Perona, Verónica Moncho-Amor, Rosario Machado-Pinilla, Cristóbal Belda-Iniesta & Isabel Sánchez Pérez. (2008) Role of CHK2 in cancer development. Clinical and Translational Oncology 10:9, pages 538-542.
Crossref
Min Huang, Ze-Hong Miao, Hong Zhu, Yu-Jun Cai, Wei Lu & Jian Ding. (2008) Chk1 and Chk2 are differentially involved in homologous recombination repair and cell cycle arrest in response to DNA double-strand breaks induced by camptothecins. Molecular Cancer Therapeutics 7:6, pages 1440-1449.
Crossref
Jun Yan, Xiao-Ping Yang, Yong-Sik Kim & Anton M. Jetten. (2008) RAP80 Responds to DNA Damage Induced by Both Ionizing Radiation and UV Irradiation and Is Phosphorylated at Ser205. Cancer Research 68:11, pages 4269-4276.
Crossref
Longchuan Chen, Christian J. Nievera, Alan Yueh-Luen Lee & Xiaohua Wu. (2008) Cell Cycle-dependent Complex Formation of BRCA1·CtIP·MRN Is Important for DNA Double-strand Break Repair. Journal of Biological Chemistry 283:12, pages 7713-7720.
Crossref
Simonne Longerich, Brian J. Orelli, Richard W. Martin, Douglas K. Bishop & Ursula Storb. (2008) Brca1 in immunoglobulin gene conversion and somatic hypermutation. DNA Repair 7:2, pages 253-266.
Crossref
Akihisa TAKAHASHI, Nobuhiro YAMAKAWA, Tadaaki KIRITA, Katsunori OMORI, Noriaki ISHIOKA, Yoshiya FURUSAWA, Eiichiro MORI, Ken OHNISHI & Takeo OHNISHI. (2008) DNA Damage Recognition Proteins Localize along Heavy Ion Induced Tracks in the Cell Nucleus. Journal of Radiation Research 49:6, pages 645-652.
Crossref
Kendra L. CannGeoffrey G. Hicks. (2007) Regulation of the cellular DNA double-strand break response. Biochemistry and Cell Biology 85:6, pages 663-674.
Crossref
Laurent Antoni, Nayanta Sodha, Ian Collins & Michelle D. Garrett. (2007) CHK2 kinase: cancer susceptibility and cancer therapy – two sides of the same coin?. Nature Reviews Cancer 7:12, pages 925-936.
Crossref
Richard W. Martin, Brian J. Orelli, Mitsuyoshi Yamazoe, Andy J. Minn, Shunichi Takeda & Douglas K. Bishop. (2007) RAD51 Up-regulation Bypasses BRCA1 Function and Is a Common Feature of BRCA1 -Deficient Breast Tumors . Cancer Research 67:20, pages 9658-9665.
Crossref
Huan-Ming Hsu, Hui-Chun Wang, Sou-Tong Chen, Giu-Cheng Hsu, Chen-Yang Shen & Jyh-Cherng Yu. (2007) Breast Cancer Risk Is Associated with the Genes Encoding the DNA Double-Strand Break Repair Mre11/Rad50/Nbs1 Complex. Cancer Epidemiology, Biomarkers & Prevention 16:10, pages 2024-2032.
Crossref
Elizabeth M. Kass, Jinwoo Ahn, Tomoaki Tanaka, William A. Freed-Pastor, Susan Keezer & Carol Prives. (2007) Stability of Checkpoint Kinase 2 Is Regulated via Phosphorylation at Serine 456. Journal of Biological Chemistry 282:41, pages 30311-30321.
Crossref
Y-M Jeng, S Cai-Ng, A Li, S Furuta, H Chew, P-L Chen, E-Y-H Lee & W-H Lee. (2007) Brca1 heterozygous mice have shortened life span and are prone to ovarian tumorigenesis with haploinsufficiency upon ionizing irradiation. Oncogene 26:42, pages 6160-6166.
Crossref
Alejandro D. Treszezamsky, Lisa A. Kachnic, Zhihui Feng, Junran Zhang, Chake Tokadjian & Simon N. Powell. (2007) BRCA1- and BRCA2-Deficient Cells Are Sensitive to Etoposide-Induced DNA Double-Strand Breaks via Topoisomerase II. Cancer Research 67:15, pages 7078-7081.
Crossref
Lih-Ching Hsu. (2007) Identification and functional characterization of a PP1-binding site in BRCA1. Biochemical and Biophysical Research Communications 360:2, pages 507-512.
Crossref
Ranjit S. Bindra, Meredith E. Crosby & Peter M. Glazer. (2007) Regulation of DNA repair in hypoxic cancer cells. Cancer and Metastasis Reviews 26:2, pages 249-260.
Crossref
Jun Yan, Yong-Sik Kim, Xiao-Ping Yang, Li-Ping Li, Grace Liao, Fen Xia & Anton M. Jetten. (2007) The Ubiquitin-Interacting Motif–Containing Protein RAP80 Interacts with BRCA1 and Functions in DNA Damage Repair Response. Cancer Research 67:14, pages 6647-6656.
Crossref
Ugo Déry & Jean-Yves Masson. (2007) Twists and turns in the function of DNA damage signaling and repair proteins by post-translational modifications. DNA Repair 6:5, pages 561-577.
Crossref
Luigi Carlessi, Giacomo Buscemi, Gary Larson, Zhi Hong, Jim Zhen Wu & Domenico Delia. (2007) Biochemical and cellular characterization of VRX0466617, a novel and selective inhibitor for the checkpoint kinase Chk2. Molecular Cancer Therapeutics 6:3, pages 935-944.
Crossref
El Mustapha Bahassi, C. Gail Penner, Susan B. Robbins, Elisia Tichy, Estrella Feliciano, Moying Yin, Li Liang, Li Deng, Jay A. Tischfield & Peter J. Stambrook. (2007) The breast cancer susceptibility allele CHEK2*1100delC promotes genomic instability in a knock-in mouse model. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 616:1-2, pages 201-209.
Crossref
Cuiying Xiao, Judith A. Sharp, Misako Kawahara, Albert R. Davalos, Michael J. Difilippantonio, Ying Hu, Wenmei Li, Liu Cao, Ken Buetow, Thomas Ried, Brian P. Chadwick, Chu-Xia Deng & Barbara Panning. (2007) The XIST Noncoding RNA Functions Independently of BRCA1 in X Inactivation. Cell 128:5, pages 977-989.
Crossref
Yutian Wang, Timothy Wiltshire, Jamie Senft, Eddie Reed & Weixin Wang. (2007) Irofulven induces replication-dependent CHK2 activation related to p53 status. Biochemical Pharmacology 73:4, pages 469-480.
Crossref
L. Eric Huang, Ranjit S. Bindra, Peter M. Glazer & Adrian L. Harris. (2006) Hypoxia-induced genetic instability—a calculated mechanism underlying tumor progression. Journal of Molecular Medicine 85:2, pages 139-148.
Crossref
Christiana DelloRusso, Piri L. Welcsh, Weixin Wang, Rochelle L. Garcia, Mary-Claire King & Elizabeth M. Swisher. (2007) Functional Characterization of a Novel BRCA1-Null Ovarian Cancer Cell Line in Response to Ionizing Radiation. Molecular Cancer Research 5:1, pages 35-45.
Crossref
David P. Steensma. 2007. Acute Myelogenous Leukemia. Acute Myelogenous Leukemia 97 131 .
Paul B. Mullan, Julia J. Gorski & D. Paul Harkin. (2006) BRCA1—A good predictive marker of drug sensitivity in breast cancer treatment?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1766:2, pages 205-216.
Crossref
Junqing Zhou, Chang UK Lim, Jian Jian Li, Lu Cai & Ying Zhang. (2006) The role of NBS1 in the modulation of PIKK family proteins ATM and ATR in the cellular response to DNA damage. Cancer Letters 243:1, pages 9-15.
Crossref
K Gudmundsdottir & A Ashworth. (2006) The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability. Oncogene 25:43, pages 5864-5874.
Crossref
Nuala McCabe, Nicholas C. Turner, Christopher J. Lord, Katarzyna Kluzek, Aneta Białkowska, Sally Swift, Sabrina Giavara, Mark J. O'Connor, Andrew N. Tutt, Małgorzata Z. Zdzienicka, Graeme C.M. Smith & Alan Ashworth. (2006) Deficiency in the Repair of DNA Damage by Homologous Recombination and Sensitivity to Poly(ADP-Ribose) Polymerase Inhibition. Cancer Research 66:16, pages 8109-8115.
Crossref
Da-Tian Bau, Yi-Chien Mau & Chen-Yang Shen. (2006) The role of BRCA1 in non-homologous end-joining. Cancer Letters 240:1, pages 1-8.
Crossref
Xiaowei Chen, Cletus A. Arciero, Chunrong Wang, Dominique Broccoli & Andrew K. Godwin. (2006) BRCC36 Is Essential for Ionizing Radiation–Induced BRCA1 Phosphorylation and Nuclear Foci Formation. Cancer Research 66:10, pages 5039-5046.
Crossref
Yuesheng Jin, Fredrik Mertens, Carl-Magnus Kullendorff & loannis Panagopoulos. (2006) Fusion of the Tumor-Suppressor Gene CHEK2 and the Gene for the Regulatory Subunit B of Protein Phosphatase 2 PPP2R2A in Childhood Teratoma. Neoplasia 8:5, pages 413-418.
Crossref
Eliot M. Rosen, Saijun Fan & Yongxian Ma. (2006) BRCA1 regulation of transcription. Cancer Letters 236:2, pages 175-185.
Crossref
Xiaoming Wu, Steven M. Shell, Zhengguan Yang & Yue Zou. (2006) Phosphorylation of Nucleotide Excision Repair Factor Xeroderma Pigmentosum Group A by Ataxia Telangiectasia Mutated and Rad3-Related–Dependent Checkpoint Pathway Promotes Cell Survival in Response to UV Irradiation. Cancer Research 66:6, pages 2997-3005.
Crossref
Jonine L. Bernstein, Sharon N. Teraoka, Esther M. John, Irene L. Andrulis, Julia A. Knight, Robert Lapinski, Eric R. Olson, Abigail L. Wolitzer, Daniela Seminara, Alice S. Whittemore & Patrick Concannon. (2006) The CHEK2*1100delC Allelic Variant and Risk of Breast Cancer: Screening Results from the Breast Cancer Family Registry . Cancer Epidemiology, Biomarkers & Prevention 15:2, pages 348-352.
Crossref

Displaying 200 of 234 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.